证券日报网讯 1月9日，汇创达发布公告称，公司于2025年9月16日召开第四届董事会第四次会议、2025 年10月10日召开2025年第二次临时股东会，审议通过了关于公司向不特定对象发行可转换公司债券（简 称"本次发行"）的相关议案。公司聘请了浙商证券股份有限公司（简称"浙商证券"）担任公司本次发行 的保荐机构、主承销商，根据《证券发行上市保荐业务管理办法》的相关规定，浙商证券作为公司新聘 请的保荐机构，将完成原保荐机构东吴证券股份有限公司未完成的持续督导工作。鉴于公司保荐机构已 更换，为保证募集资金督导工作的正常进行，保护投资者权益，根据相关规定，近日公司、全资子公司 东莞市聚明电子科技有限公司与招商银行股份有限公司深圳分行、保荐机构浙商证券重新签订了《募集 资金专户四方监管协议》。 （文章来源：证券日报） ...

智通财经APP获悉，东吴证券发布研报称，在AIDC建设加速背景下，电力供需缺口持续放大，燃气轮 机行业有望开启新一轮上行周期。AI数据中心建设带来大量用电需求，且对电力的可靠性、稳定性提 出较高要求。燃机市场替代空间大，看好国内设备商受益机会。 投资建议 在需求爆发+供给受限+国产替代的格局下，燃气轮机行业推荐高额燃机订单持续落地【杰瑞股份】、 聚焦高技术壁垒透平叶片国产替代【应流股份】、燃机缸体与环类主力供应商【豪迈科技】、卡特彼勒 供应商【联德股份】。 风险提示 AI数据中心投资不及预期、国际贸易摩擦、国产替代不及预期。 在AIDC建设加速背景下，电力供需缺口持续放大，燃气轮机行业有望开启新一轮上行周期 ①供需格局：需求端快速释放，而供给受制于供应链约束及3–5年的交付周期显著滞后，2025年全球燃 机意向订单已超80GW，实际可交付产能不足50GW，供需缺口明确；②分功率产品优势：重型燃机具 备大功率、长期稳定运行优势，中小型燃机在灵活性与可靠性方面更具优势，均可适配AIDC用电需 求，其中中小型燃机在数据中心场景下需求弹性更强，相关机组订单增速显著；③区域分布：北美与中 东形成双轮驱动格局，美国电力系 ...

东吴证券研报指出，古井贡酒周期底部报表出清可期，动销韧性强复苏第一梯队有望。从行业节奏来 看，2026年动销抓手仍是大众消费场景，同时从古井自身节奏来看，深度调整期管理团队稳定有助于销 售策略连续性更利于穿越周期；中期而言，古井省内优势稳固，坚定"全国化、次高端"战略，省外规模 化市场有望培育成型和复制。基于短期和中期判断，古井在白酒中投资排序靠前，维持"买入"评级。 ...

Core Insights - The year 2026 marks the beginning of the "14th Five-Year Plan" and is seen as a pivotal moment for China's asset management industry, facing new opportunities amid ongoing international volatility and the transformative impact of AI on investment research [2] - The upcoming HED China Summit aims to address critical questions regarding policy direction, low interest rate challenges, and the potential disruption caused by AI in asset allocation decisions [2] Group 1: Macro Outlook - Dongwu Securities' Chief Economist, Lu Zhe, will provide an in-depth analysis of the "New Cycle of the 14th Five-Year Plan: Asset Allocation Outlook," covering growth and structural targets, fiscal and monetary policy coordination, and trends in exchange rates and commodities [4] - A roundtable discussion featuring experts from major banks will combine macro policy guidance with wealth management experience, offering strategic insights for the industry [4] Group 2: Practical Strategies - The summit will focus on actionable solutions to asset allocation challenges in a low-interest-rate environment, with presentations on global macroeconomic trends and multi-asset strategies [5] - Insights into the futures asset management sector and its investment strategies for 2026 will be shared by industry leaders [6] Group 3: Quantitative Focus - A dedicated forum on "The Next Phase of Chinese Quantitative Strategies" will address key concerns in the quantitative field, including innovations in quantitative stock strategies and the development of cross-border funds [7] - Discussions will also focus on the opportunities for institutional funds in quantitative stock strategies, facilitating connections between quantitative firms and mainstream investors [7] Group 4: Efficient Collaboration - The summit emphasizes practical outcomes by facilitating high-efficiency business connections between mainstream institutional investors and private fund managers through tailored networking opportunities [8] Group 5: Industry Recognition - The "19th Jiefu Honor Night" awards ceremony will recognize outstanding contributions in asset management, insurance, and banking, serving as a benchmark for excellence in the industry [9] - The summit aims to create a high-level exchange platform for industry elites to address challenges and seize opportunities, contributing to the high-quality development of the asset management sector in 2026 [9]

Core Viewpoint - Dongwu Securities initiates coverage on Meili Tianyuan Medical Health (02373) with a "Buy" rating, highlighting its unique "Double Beauty + Double Health" ecosystem, proven acquisition integration capabilities, and excellent operational efficiency, which are expected to drive significant growth in the industry [1] Group 1: Company Overview - The company, established in 1993, has developed a comprehensive beauty and health management service system that includes traditional beauty, medical beauty, and sub-health assessment and intervention [2] - It operates four major brands: Meili Tianyuan, Beili Shi, Xiuker, and Yanyuan, and has strengthened its market position through acquisitions of Nairui'er and Siyuanli, forming a synergistic ecosystem of "life beauty + medical beauty + traditional health + sub-health medical" [2] Group 2: Financial Performance - The company demonstrates strong growth resilience, with revenue increasing from 1.503 billion in 2020 to 2.572 billion in 2024, representing a compound annual growth rate (CAGR) of 11.3% [3] - In the first half of 2025, revenue accelerated to 1.459 billion, a year-on-year increase of 28.2% [3] - Net profit attributable to shareholders rose from 151 million in 2020 to 228 million in 2024, with a year-on-year growth of 34.9% in the first half of 2025, reaching 156 million [3] - Gross margin improved to 49.33% in the first half of 2025, while net margin optimized to 10.67%, reflecting effective cost control and an increase in high-margin business [3] - The company commits to a dividend payout ratio of no less than 50% of net profit attributable to shareholders over the next three years, indicating strong dividend levels [3] Group 3: Industry Outlook - The traditional beauty, light medical beauty, and sub-health sectors are expected to continue expanding, with projected market sizes of 640.2 billion, 415.7 billion, and 29 billion respectively by 2030 [4] - As young consumers increasingly prioritize standardized services and stable experiences, leading companies are expected to gain significant advantages, leading to higher market concentration [4] - The overlapping consumer base in traditional beauty and light medical beauty allows for effective cross-referrals, enhancing customer conversion rates [4] Group 4: Business Synergy and Growth Strategy - The company's core business model exhibits strong synergy, utilizing its extensive and trusted life beauty services as a front-end traffic source to efficiently convert to high-ticket medical beauty and sub-health services, with a cross-business conversion rate of 28.7% in 2024 [5] - The company employs a strategy of "directly operated stores as benchmarks, franchising for coverage," leading to rapid expansion of its store network, which is expected to reach 554 by the end of 2024 [5] - The company has a robust target selection system and post-acquisition digital integration capabilities, as evidenced by the significant improvement in net margin following the acquisition of Nairui'er, showcasing its strong integration and empowerment capabilities [5]

Core Viewpoint - Dongwu Securities initiates coverage on Meili Tianyuan Healthcare (02373) with a "Buy" rating, highlighting its unique "Double Beauty + Double Health" ecological model, proven acquisition integration capabilities, and excellent operational efficiency, which are expected to drive sustained industry leadership and significant growth [1] Group 1: Company Overview - Established in 1993, the company has developed a comprehensive beauty and health management service system covering traditional beauty, medical beauty, and sub-health assessment and intervention [2] - The company owns four major brands: Meili Tianyuan, Beili Shi, Xiuker, and Yanyuan, and has strengthened its industry position through acquisitions of Nairui'er and Siyuanli, forming a synergistic ecological closed loop [2] Group 2: Financial Performance - The company demonstrates strong growth resilience, with revenue increasing from 1.503 billion in 2020 to 2.572 billion in 2024, representing a compound annual growth rate (CAGR) of 11.3% [3] - In the first half of 2025, revenue accelerated to 1.459 billion, a year-on-year increase of 28.2% [3] - Net profit attributable to shareholders rose from 151 million in 2020 to 228 million in 2024, with a year-on-year growth of 34.9% in the first half of 2025, reaching 156 million [3] - Gross margin improved to 49.33% in the first half of 2025, while net margin optimized to 10.67%, reflecting effective cost control and a higher proportion of high-margin business [3] - The company commits to a dividend payout ratio of no less than 50% of net profit attributable to shareholders over the next three years, indicating strong dividend levels [3] Group 3: Industry Outlook - The traditional beauty, light medical beauty, and sub-health sectors are expected to see long-term growth, with market sizes projected to reach 640.2 billion, 415.7 billion, and 29 billion respectively by 2030 [4] - As young consumers increasingly prioritize standardized services and stable experiences, the competitive landscape is expected to consolidate further, benefiting leading companies [4] Group 4: Business Synergy and Growth Strategy - The company's core business model exhibits significant synergy, utilizing its extensive and trusted beauty services as a front-end traffic source to efficiently convert to higher-priced medical beauty and sub-health services, with cross-business conversion rate reaching 28.7% in 2024 [5] - The company employs a strategy of "directly operated stores as benchmarks, franchising for coverage," leading to rapid expansion of its store network, totaling 554 by the end of 2024 [5] - The company has a mature target selection system and post-acquisition digital integration capabilities, as evidenced by the significant improvement in net profit margin following the acquisition of Nairui'er, validating its strong integration and empowerment capabilities [5]

国联民生证券股份有限公司（以下简称"国联民生证券"）凭借并购重组实现跨越式发展。作为新"国九 条"后首个券商并购重组案例，其资产和业绩指标较"十四五"开局跃升超20个位次，整合后的投行、研 究业务跻身全国前列，IPO申报数量稳居行业前四。 此外，南京证券股份有限公司50亿元定增落地，聚焦投行、财富管理等核心业务加大投入；东海证券股 份有限公司则深化战略转型，强化常州本土服务与资源倾斜，业绩实现大幅增长，形成了多元协同的发 展格局。 "十四五"时期，资本市场改革持续深化，服务实体经济能力稳步提升。作为经济大省的江苏，证券行业 在此期间实现跨越式发展，不仅整体实力迈上新台阶，更累计助力企业实现直接融资超7万亿元，服务 客户规模超3200万户，以特色行业文化践行金融向善理念，为全省经济"走在前、做示范"注入强 劲"证"能量，交出了一份分量十足的发展答卷。 多元协同发展 行业综合实力稳步跃升 《证券日报》记者从江苏证监局获悉，"十四五"期间，江苏法人证券公司总资产逼近1.6万亿元，较"十 三五"末增长62%，净资产增幅较全国平均水平高出20个百分点，累计实现净利润868亿元，服务客户规 模超3200万户。机构布局方面 ...

技术路线以MoE架构为核心，早于多数同行布局多模态并行研发 公司全栈自研，研发效率高，截至2025年9月累计投入研发约5亿美元。2025年迭代多个模型：Speech系 列在语音生成领域领先，Hailuo系列视频模型在全球基准测试中位居前列，开源模型MiniMax-M1和M2 在Artificial Analysis榜单表现突出。竞争优势主要体现在三个方面。第一，全球化执行力强。Talkie在海 外AI伴侣赛道领先，海螺AI视频生成用量大，海外市场付费意愿高，避免价格战。第二，双轮模式均 衡。消费者业务提供规模和数据，企业业务保障高毛利和稳定性，抗风险能力较好。第三，研发效率领 先。团队年轻化、扁平化管理，结合MoE和自研基础设施，单位算力产出高。 东吴证券发布研报称，MINIMAX-WP(00100)成立于2021年12月，专注通用人工智能基础技术研发，目 标是构建国际竞争力的多模态大模型，并面向全球市场提供产品和服务。从成立之初，公司就选择全球 化定位，同时布局消费者产品和海外渠道。2025/12/21通过港交所聆讯，12月31日启动港股IPO，股票 代码0100，发行估值461-504亿港元，计划募资超过 ...

公司商业模式采取ToC和ToB双轮驱动 消费者业务主要包括Talkie/星野（角色互动娱乐）和海螺AI（文生视频），贡献收入主体，提供现金流 和海量交互数据。开发者企业业务通过API调用、专属资源服务和模型授权实现，高毛利特性明显。两 者形成协同：消费者端数据反哺模型迭代，企业端需求引导技术优先级，增长飞轮已初步显现。截至 2025/9/30，公司产品覆盖个人用户超过2.12亿，覆盖200多个国家和地区；企业和开发者客户超过10 万，分布在100多个国家。收入快速增长，规模效应显现。2023年收入346万美元，2024年增长至3052万 美元，同比增幅超过7倍；2025年前九个月收入5344万美元，同比增长174%。 技术路线以MoE架构为核心，早于多数同行布局多模态并行研发 公司全栈自研，研发效率高，截至2025年9月累计投入研发约5亿美元。2025年迭代多个模型：Speech系 列在语音生成领域领先，Hailuo系列视频模型在全球基准测试中位居前列，开源模型MiniMax-M1和M2 在Artificial Analysis榜单表现突出。竞争优势主要体现在三个方面。第一，全球化执行力强。Talkie在海 ...

Core Viewpoint - Dongwu Securities expresses optimism about Zhipu AI's strengths in local model technology, open-source ecosystem, and local implementation capabilities, anticipating stable growth in local business and cloud services as the main growth driver, suggesting to pay attention to the company [1] Company Overview - Zhipu AI, established in 2019, is a leading independent general large model developer in China, originating from Tsinghua University's Knowledge Engineering Group (KEG) [1] - The company has developed its own GLM (General Language Model) pre-training framework, which differs from mainstream GPT architectures, offering unique advantages in long text understanding, logical reasoning, and low hallucination rates [1] - Zhipu AI follows a dual strategy of open-source and commercialization, creating a comprehensive model matrix covering language, multimodal, code, and intelligent agent fields, with flagship products GLM-4.5 and GLM-4.7 ranking high in international benchmark tests [1] Market Position - According to Frost & Sullivan data, Zhipu AI ranks first among independent general large model developers in China and second overall, with a market share of 6.6% as of 2024 [2] - By mid-2025, the company has served over 8,000 institutional clients, with 9 out of the top 10 internet companies in China using GLM models [2] - The global download volume of open-source models exceeds 45 million, with over 2.7 million registered developers on the MaaS platform, and daily token consumption reaching 4.2 trillion by November 2025 [2] Business Model - The business model centers around the MaaS (Model as a Service) platform, driven by both localized and cloud deployments [3] - Localized deployment targets government and enterprise clients, providing private operation and customization services, accounting for 84.8% of revenue in the first half of 2025 with a gross margin of 59% [3] - Cloud deployment, through API calls and subscription services, is rapidly growing, making up 15.2% of revenue in the first half of 2025, with a focus on increasing API revenue share in the long term [3] Financial Performance - Historical financial performance shows high revenue growth, with revenues of 0.57 million, 1.25 million, and 3.12 million yuan from 2022 to 2024, reflecting a compound annual growth rate of over 130% [3] - In the first half of 2025, revenue reached 1.91 billion yuan, a year-on-year increase of 325%, surpassing the total revenue for 2023 [3] IPO Details - The IPO price is set at 116.20 HKD per share, with a global offering of 37.42 million H shares, raising approximately 4.3 billion HKD, leading to a market capitalization of about 51.1 billion HKD post-funding [4] - The raised funds will primarily enhance general large model research (about 70%), optimize the MaaS platform infrastructure (about 10%), expand ecosystem cooperation and strategic investments (about 10%), and supplement working capital [4] - Key investors include prominent institutions such as Shanghai Gao Yi, GF Fund, and Taikang Life, with the founding team controlling about 33% of shares through a concerted action agreement [4] Competitive Advantages - The company's core competitive advantages lie in its full-stack self-research technology system, leading model performance, open-source ecosystem, and deep adaptation to domestic computing power [4] - The R&D personnel account for 74%, with a core team from Tsinghua KEG, possessing deep academic accumulation in natural language processing [4] - The rapid iteration of the GLM series, particularly GLM-4.7, shows strong performance in programming scenarios, while AutoGLM enables AI to autonomously operate smartphones and computer GUIs, marking a new paradigm for agents [4] Revenue Forecast - Revenue projections for 2025-2027 are estimated at 790 million (up 151%), 1.55 billion (up 97%), and 3.22 billion (up 108%), with a gradual shift from localized to cloud-dominated revenue structure [5] - The overall gross margin is expected to reach 50% in 2025, stabilizing around 51% in 2026-2027, with cloud gross margins improving from low levels to 40% [5] - The valuation for Zhipu AI in 2026 is projected at a PS ratio of 30 times, higher than comparable companies, but with significant room for compression as revenue grows rapidly [5]